1.0T MR‐guided percutaneous coaxial cutting needle biopsy in pancreatic lesion diagnosis

Liu, Chao; Wang, Ligang; He, Xijing; Xu, Yanjun; Lu, Dong; Li, Peipei; Lv, Rongbin; Feng, Yong; Liu, Ming; Li, Chengli

doi:10.1002/jmri.25952

Cited by 6 publications

(2 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The first MRI-guided clinical trials were reported in 1986 (13). Since then, MRI-guided clinical applications have been successfully applied to lesions in various anatomical regions, such as pancreatic, breast, prostate, lung tumor, and renal tumor lesions (14)(15)(16)(17)(18). After ∼20 years of clinical use, MRIguided breast biopsy has evolved into a routine method in Western European countries (19,20).…”

Section: Discussionmentioning

confidence: 99%

Clinical Application and Feasibility of MRI-Guided Breast Biopsy of Breast Minimal Lesions in Chinese Population

et al. 2020

View full text Add to dashboard Cite

Objectives: Some breast lesions are not visible on mammography or ultrasonography, and magnetic resonance imaging (MRI) become the only way to monitor these lesions. The purpose of this study was to evaluate the clinical application of MRI-guided biopsy and MRI-guided wire localization of breast minimal lesions in Chinese population. Methods:We evaluated 95 patients (the most patients of known in China) from August 2013 to December 2017. All the patients were scanned with a 1.5-Tesla MRI system (GE Medical Systems, America) in the prone position using a bilateral 8-channel phased-array breast coil and underwent MRI-guided wire localization or MRI-guided biopsy.Results: MRI-guided wire localization and MRI-guided biopsy were successfully performed in 87 patients with 88 lesions (100%, 88/88). After biopsy or surgery, 36 of 88 lesions (40.91%) were malignant, and 52 of 88 lesions (59.09%) were benign. Thirty-nine of 88 lesions (44.32%) were masses, and 49 of 88 (55.68%) showed non-mass enhancement. Statistical analysis showed there was no significant correlation between the malignancy rate and the type of lesion on MRI (P = 0.27). In this study, the rate of malignancy for Breast Imaging-Reporting and Data System (BI-RADS) 5 lesions was 100% (2 of 2) compared with 44.44% for BI-RADS 4C lesions (4 of 9), 42.42% for BI-RADS 4B lesions (14 of 33), and 36.36% for BI-RADS 4A lesions (16 of 44).Conclusions: MRI-guided wire localization with subsequent surgical biopsy and MRI-guided biopsy are safe and effective tools for breast minimal lesions.

show abstract

Section: Discussionmentioning

confidence: 99%

Clinical Application and Feasibility of MRI-Guided Breast Biopsy of Breast Minimal Lesions in Chinese Population

et al. 2020

View full text Add to dashboard Cite

show abstract

“…[10][11][12][13] Usually, to keep the procedure of percutaneous needle biopsy as safe as possible, the procedure is under the guidance of different image modalities, such as computer tomography (CT), 12,14,15 ultrasound (US), [16][17][18] and magnetic resonance (MR). [19][20][21] Among these three major modalities, CT is used in most percutaneous needle biopsy procedures since it can balance the image quality and cost.…”

Section: Introductionmentioning

confidence: 99%

A newly developed image fusion algorithm between CECT image and CT image: A feasibility study

Wang

et al. 2022

Proc Inst Mech Eng H

View full text Add to dashboard Cite

Cancer cases have been on the rise over the world. Cancer treatment can benefit from an early accurate diagnosis. Percutaneous needle biopsy under the guidance of CT images is the most common method to obtain tumor samples for accurate diagnosis. However, due to the lack of vascular information in the CT images, the biopsy procedure is at great risk, especially for the tumor surrounded by vessels. In this study, a biomechanical model and surface elastic registration-based fusion algorithm were developed to map the vessels from contrast-enhanced CT images of the liver and lung to the corresponded CT image. Radiologists could observe vessels in the CT images during the biopsy procedure so that the risk can be decreased. The developed algorithm was tested through 20 groups of lung data and 16 groups of liver data. The results show that the fusion errors (mean ± standard deviation) were 2.35 ± 0.85, 2.08 ± 0.41, 2.31 ± 0.49, and 2.37 ± 0.62 mm for portal vein, hepatic vein, pulmonary artery, and pulmonary vein, respectively. The accuracy of this method was satisfied in clinical application

show abstract

Percutaneous Magnetic Resonance Imaging-Guided Coaxial Cutting Needle Biopsy of Pancreatic Lesions: Diagnostic Accuracy and Safety

Zhang

Jin

Dai

et al. 2023

Cardiovasc Intervent Radiol

View full text Add to dashboard Cite

1.0T MR‐guided percutaneous coaxial cutting needle biopsy in pancreatic lesion diagnosis

Abstract: 2 Technical Efficacy: Stage 2 J. MAGN. RESON. IMAGING 2018;48:382-388.

Cited by 6 publications

References 41 publications

Clinical Application and Feasibility of MRI-Guided Breast Biopsy of Breast Minimal Lesions in Chinese Population

Clinical Application and Feasibility of MRI-Guided Breast Biopsy of Breast Minimal Lesions in Chinese Population

A newly developed image fusion algorithm between CECT image and CT image: A feasibility study

Percutaneous Magnetic Resonance Imaging-Guided Coaxial Cutting Needle Biopsy of Pancreatic Lesions: Diagnostic Accuracy and Safety

Contact Info

Product

Resources

About